Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Recro Pharma Inc (REPH)’

Copyright: nexusplexus / 123RF Stock Photo

Recro Pharma, Inc. (REPH): Here are Midwood Capital Management’s Thoughts On The Pharmaceutical Company

Midwood Capital Management explained recent Recro Pharma (NASDAQ:REPH) stock price fluctuations in its Q1 2019 Investor Letter. If you are interested......(read more)
30 Funniest Science Jokes, Puns, and Humor Quotes Ever

Here is What Artko Capital Thinks About Recro Pharma, Inc. (REPH)

Artko Capital recently released its Q1 2019 Investor Letter, which you can track down here. In it, the fund reported its quarterly return of 10.3% and......(read more)
30 Funniest Science Jokes, Puns, and Humor Quotes Ever

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
easiest countries to get oxycodone prescribed

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
lab, laboratory, clinic, clinical, scientist, researching, research, chemist, medical, man, male, specialist, focus, chemistry, test, science

Recro Pharma Inc (REPH): Here’s What’s Next

Recro Pharma Inc (NASDAQ:REPH) is one of the week’s runners in biotech so far. The company just put out data from a late stage trial and gained......(read more)
Broadfin Kevin Kotler

Recro Pharma Inc. (REPH): Largest Shareholder Broadfin Capital Buys Even More Shares

An amended 13D filing with the Securities and Exchange Commission showed that Kevin Kotler‘s Broadfin Capital has acquired more shares of Recro......(read more)
Biotech Lab Testing

A Look At Recro Pharma Inc (REPH) and Alkermes Plc (ALKS)’s Topline Triumph

Recro Pharma Inc (NASDAQ:REPH) is up more than 27% on Wednesday after announcing data from its lead acute pain trial. The company has developed an IV......(read more)
Jason Karp - Tourbillon Capital Partners

Jason Karp Takes Long Position In This Stock, Up By 480% This Year

Jason Karp’s Tourbillon Capital Partners recently filed a 13G form with the SEC indicating that it now owns 7.0% of the common shares of Recro Pharma......(read more)
Broadfin Kevin Kotler

Healthcare Expert Kevin Kotler Boosts His Stake In Recro Pharma Inc. (REPH)

Kevin Kotler’s Broadfin Capital has filed a 13D with the Securities and Exchange Commission regarding its stake in Recro Pharma Inc. (NASDAQ:REPH).......(read more)
Rishi Bajaj - Altai Capital

Servicesource International Inc (SREV), Recro Pharma Inc (REPH): Altai Capital And Broadfin Capital’s Latest Moves

According to a recent filing with the Securities and Exchange Commission, Altai Capital, run by Rishi Bajaj, Toby Symonds and Steve Tesoriere, has increased......(read more)
Oxygen Biotherapeutics

Hal Mintz, Sabby Management Report 7.43% Stake in Oxygen Biotherapeutics, Inc. (OXBT)

Hal Mintz‘ Sabby Management has reported a new stake in the biotechnology company Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), a new filing with......(read more)
BiolineRX

Sabby Management Adds Bioline RX Ltd (BLRX) & Recro Pharma Inc (REPH) to Its Equity Portfolio

In a couple of new filings with the SEC, Hal Mintz‘s Sabby Management disclosed adding two companies to its equity portfolio: Bioline RX Ltd (NASDAQ......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates Stake in Newly Public Recro Pharma Inc (REPH)

Broadfin Capital, managed by Kevin Kotler, has disclosed in a new filing with the U.S. Securities and Exchange Commission holding shares of Recro Pharma......(read more)